PDF (1347K)
摘要
无偿献血是临床用血安全的基石。面对人口结构转型与医疗需求增长带来的血液供应压力,科学设定全血献血间隔期成为提升血液供应能力的关键方向。我国现行6个月的全血献血间隔期标准与国际主流实践存在差异。本共识依据《世界卫生组织指南制定手册》,系统检索并评价全血献血间隔期相关证据,采用GRADE(Grading of Recommendations Assessment, Development and Evaluation)方法评价证据质量,并通过改良德尔菲法开展专家咨询,形成共识推荐意见;基于生理学证据与循证研究,系统评估了缩短间隔期对献血者健康、血液质量及受血者安全的影响,以及其对血液供应量可能的贡献。推荐在完善健康监测的前提下,将全血献血间隔期调整为3个月,可在保障安全的同时有效提升血液供应,为我国献血政策的优化提供循证依据。
Abstract
Voluntary blood donation is the cornerstone of safe clinical blood use. In the context of demographic transition and growing healthcare demand, scientifically determining an appropriate whole blood donation interval has become an important strategy for enhancing blood supply capacity. The current 6-month interval for whole blood donation in China differs from prevailing international practices. Based on the WHO Handbook for Guideline Development, this consensus systematically reviewed and evaluated the evidence on whole blood donation intervals, assessed the quality of evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, and conducted expert consultation using a modified Delphi method to develop consensus recommendations. Drawing on physiological evidence and findings from evidence-based studies, the consensus systematically evaluated the effects of shortening the donation interval on donor health, blood quality, and recipient safety, as well as its potential contribution to blood supply. It is recommended that, with strengthened health monitoring, the whole blood donation interval be reduced to 3 months, which can effectively enhance blood supply while ensuring safety, thereby providing an evidence-based basis for optimizing blood donation policies in China.
关键词
Key words
[Author(id=1329502491306443306, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456921556165460, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329502491352580656, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456921556165460, authorId=1329502491306443306, language=EN, stringName=Expert Consensus Writing Group of Adjustment of Whole Blood Donation Interval for Voluntary Blood Donations, firstName=null, middleName=null, lastName=Expert Consensus Writing Group of Adjustment of Whole Blood Donation Interval for Voluntary Blood Donations, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=null, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502491398718002, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456921556165460, authorId=1329502491306443306, language=CN, stringName=无偿献血全血间隔期调整的专家共识编写组, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=null, bio={"content":"王陈赢(2001-),女,硕士研究生在读,Email:wangchenying0624@163.com;胡雨薇(1999-),女,博士研究生在读,Email:yuweihu007@foxmail.com;戴姝畅(2002-),女,博士研究生在读,Email:dschang2024@163.com
"}, bioImg=null, bioContent=王陈赢(2001-),女,硕士研究生在读,Email:wangchenying0624@163.com;胡雨薇(1999-),女,博士研究生在读,Email:yuweihu007@foxmail.com;戴姝畅(2002-),女,博士研究生在读,Email:dschang2024@163.com
, aboutCorrespAuthor=null)}, companyList=null)]
无偿献血全血间隔期调整的专家共识编写组.
无偿献血全血间隔期调整的专家共识[J].
中国输血杂志, 2026, 39(9): 1157-1167 DOI:10.13303/j.cjbt.issn.1004-549x.2026.09.003
| [1] |
YU X, WANG Z, SHEN Y, et al. Population-based projections of blood supply and demand, China, 2017-2036[J].Bull World Health Organ, 2020, 98(1):10-18.
|
| [2] |
WITTOCK N, HUSTINX L, BRACKE P, et al. Who donates? Cross-country and periodical variation in blood donor demographics in Europe between 1994 and 2014[J].Transfusion, 2017, 57(11):2619-2628.
|
| [3] |
JOINT PROFESSIONAL ADVISORY COMMITTEE. Frequency of donation: whole blood and components[R/OL].(2023-05-09)[2025-12-15].https://www.jpac.org.uk/guidelines/wb/index/frequency-of-donation/.
|
| [4] |
GOLDMAN M, MAGNUSSEN K, GORLIN J, et al. International forum regarding practices related to donor haemoglobin and iron[J].Vox Sang, 2016, 111(4):449-455.
|
| [5] |
KARP J K, KING K E. International variation in volunteer whole blood donor eligibility criteria[J].Transfusion, 2010, 50(2):507-513.
|
| [6] |
COHN C S, BOCQUET C. Updates to Association for the Advancement of Blood and Biotherapies Standards for blood banks and transfusion services, 34th edition[J].Transfusion, 2024, 64(9):1628-1632.
|
| [7] |
WORLD HEALTH ORGANIZATION. Blood donor selection:guidelines on assessing donor suitability for blood donation[M]. Geneva: World Health Organization,2012.
|
| [8] |
BAART A M, VAN DEN HURK K, DE KORT W L A M. Minimum donation intervals should be reconsidered to decrease low hemoglobin deferral in whole blood donors:an observational study[J].Transfusion, 2015, 55(11):2641-2644.
|
| [9] |
GANDHI M J, DUFFY K, BENIKE M, et al. Effect of increasing hemoglobin cutoff in male donors and increasing interdonation interval in whole blood donors at a hospital-based blood donor center[J].Transfusion, 2012, 52(9):1880-1888.
|
| [10] |
SPENCER B R, JOHNSON B, WRIGHT D J, et al. Potential impact on blood availability and donor iron status of changes to donor hemoglobin cutoff and interdonation intervals[J].Transfusion, 2016, 56(8):1994-2004.
|
| [11] |
MOORE C, BOLTON T, WALKER M, et al. Recruitment and representativeness of blood donors in the INTERVAL randomised trial assessing varying inter-donation intervals[J].Trials, 2016, 17(1):458.
|
| [12] |
苏玲玲,陈镇奇,翁妙卿,等. 无偿献血的限量及安全间隔期的研究[J].临床输血与检验,2007,9(4):302-304.
|
| [13] |
SU L L, CHEN Z Q, WENG M Q, et al. Research to the satisfying blood donating volume and safe interval[J].J Clin Transfus Lab Med, 2007, 9(4):302-304.
|
| [14] |
DI ANGELANTONIO E, THOMPSON S G, KAPTOGE S, et al. Efficiency and safety of varying the frequency of whole blood donation (INTERVAL):a randomised trial of 45 000 donors[J].Lancet, 2017, 390(10110):2360-2371.
|
| [15] |
GUYATT G H, OXMAN A D, KUNZ R, et al. What is “quality of evidence” and why is it important to clinicians?[J].BMJ, 2008, 336(7651):995-998.
|
| [16] |
GUYATT G H, OXMAN A D, KUNZ R, et al. Going from evidence to recommendations[J].BMJ, 2008, 336(7652):1049-1051.
|
| [17] |
HALL J E, HALL M E. Guyton and Hall textbook of medical physiology[M]. 14th ed. Philadelphia:Elsevier,2021.
|
| [18] |
NEWMAN B H. Blood donor complications after whole-blood donation[J].Curr Opin Hematol, 2004, 11(5):339-345.
|
| [19] |
AMREIN K, VALENTIN A, LANZER G, et al. Adverse events and safety issues in blood donation--a comprehensive review[J].Blood Rev, 2012, 26(1):33-42.
|
| [20] |
YOUNG P, CROWDER L, STEELE W, et al. Frequency of rare, serious donor reactions:international perspective[J].Transfusion, 2021, 61(6):1780-1788.
|
| [21] |
WU Y, QI H, DI ANGELANTONIO E, et al. Risk factors for vasovagal reactions in blood donors:a systematic review and meta-analysis[J].Transfusion, 2025, 65(1):211-223.
|
| [22] |
THIJSEN A, MASSER B. Vasovagal reactions in blood donors:risks, prevention and management[J].Transfus Med, 2019, 29(Suppl 1):13-22.
|
| [23] |
宁理,张艳艳,曾劲峰,等. 深圳地区献血间隔期与献血不良反应相关性的回顾性队列分析[J].中国输血杂志,2026,39(3):346-352.
|
| [24] |
NING L, ZHANG Y Y, ZENG J F, et al. A retrospective cohort analysis of the association between blood donation intervals and adverse blood donation reactions in Shenzhen[J].Chin J Blood Transfusion, 2026, 39(3):346-352.
|
| [25] |
SEVERIJNS P, D’AES T, DE BUCK E, et al. What is the impact of whole-blood donation frequency on donor health? A systematic review[J].Vox Sang, 2026, 121(7):893-903.
|
| [26] |
POTTGIESSER T, SPECKER W, UMHAU M, et al. Recovery of hemoglobin mass after blood donation[J].Transfusion, 2008, 48(7):1390-1397.
|
| [27] |
WADSWORTH G R. Recovery from acute haemorrhage in normal men and women[J].J Physiol, 1955, 129(3):583-593.
|
| [28] |
ZIEGLER A K, GRAND J, STANGERUP I, et al. Time course for the recovery of physical performance, blood hemoglobin, and ferritin content after blood donation[J].Transfusion, 2015, 55(4):898-905.
|
| [29] |
STANGERUP I, KRAMP N L, ZIEGLER A K, et al. Temporary impact of blood donation on physical performance and hematologic variables in women[J].Transfusion, 2017, 57(8):1905-1911.
|
| [30] |
SIMON T L. Iron, iron everywhere but not enough to donate[J].Transfusion, 2002, 42(6):664.
|
| [31] |
KISS J E, BRAMBILLA D, GLYNN S A, et al. Oral iron supplementation after blood donation: a randomized clinical trial[J].JAMA, 2015, 313(6):575-583.
|
| [32] |
CABLE R G, GLYNN S A, KISS J E, et al. Iron deficiency in blood donors:analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study[J].Transfusion, 2011, 51(3):511-522.
|
| [33] |
BRITTENHAM G M, WEISS G, BRISSOT P, et al. Clinical consequences of new insights in the pathophysiology of disorders of iron and heme metabolism[J].Hematology Am Soc Hematol Educ Program, 2000(1):39-50.
|
| [34] |
KISS J E, BIRCH R J, STEELE W R, et al. Quantification of body iron and iron absorption in the REDS-II Donor Iron Status Evaluation (RISE) study[J].Transfusion, 2017, 57(7):1656-1664.
|
| [35] |
MANTADAKIS E, PANAGOPOULOU P, KONTEKAKI E, et al. Iron deficiency and blood donation:links, risks and management[J].J Blood Med, 2022, 13:775-786.
|
| [36] |
GANZ T, NEMETH E. Hepcidin and disorders of iron metabolism[J].Annu Rev Med, 2011, 62:347-360.
|
| [37] |
GANZ T. Systemic iron homeostasis[J].Physiol Rev, 2013, 93(4):1721-1741.
|
| [38] |
CAMASCHELLA C. Iron-deficiency anemia[J].N Engl J Med, 2015, 372(19):1832-1843.
|
| [39] |
ANDREWS N C. Forging a field:the golden age of iron biology[J].Blood, 2008, 112(2):219-230.
|
| [40] |
KISS J E. Laboratory and genetic assessment of iron deficiency in blood donors[J].Clin Lab Med, 2015, 35(1):73-91.
|
| [41] |
HURRELL R, EGLI I. Iron bioavailability and dietary reference values[J].Am J Clin Nutr, 2010, 91(5):1461S-1467S.
|
| [42] |
HALLBERG L, HULTHÉN L. Prediction of dietary iron absorption: an algorithm for calculating absorption and bioavailability of dietary iron[J].Am J Clin Nutr, 2000, 71(5):1147-1160.
|
| [43] |
SMITH G A, FISHER S A, DOREE C, et al. Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors[J].Cochrane Database Syst Rev, 2014(7):CD009532.
|
| [44] |
GOLDMAN M, UZICANIN S, OSMOND L, et al. A large national study of ferritin testing in Canadian blood donors[J].Transfusion, 2017, 57(3):564-570.
|
| [45] |
KALUS U, PRUSS A, WODARRA J, et al. Influence of blood donation on levels of water-soluble vitamins[J].Transfus Med, 2008, 18(6):360-365.
|
| [46] |
BOOTH C K, CLARK T, FENN A. Folic acid, riboflavin, thiamine, and vitamin B-6 status of a group of first-time blood donors[J].Am J Clin Nutr, 1998, 68(5):1075-1080.
|
| [47] |
CAFOLLA A, DRAGONI F, GIRELLI G, et al. Folate status in Italian blood donors: relation to gender and smoking[J].Haematologica, 2000, 85(7):694-698.
|
| [48] |
ROSENTHAL J, MILLA G, FLORES A, et al. Effect of different dosage and administration schedules of folic acid on blood folate levels in a population of Honduran women of reproductive age[J].Public Health Nutr, 2008, 11(8):822-830.
|
| [49] |
ZAPPACOSTA B, PERSICHILLI S, IACOVIELLO L, et al. Folate, vitamin B12 and homocysteine status in an Italian blood donor population[J].Nutr Metab Cardiovasc Dis, 2013, 23(5):473-480.
|
| [50] |
KANIAS T, STONE M, PAGE G P, et al. Frequent blood donations alter susceptibility of red blood cells to storage-and stress-induced hemolysis[J].Transfusion, 2019, 59(1):67-78.
|
| [51] |
TAN J C G, CHA Y, AUNG H H, et al. Haemolysis in red blood cell components is associated with donor ferritin and body mass index status, but not donation frequency[J].Transfus Apher Sci, 2024, 63(6):104009.
|
| [52] |
LIVSHITS L, BARSHTEIN G, ARBELL D, et al. Do we store packed red blood cells under “quasi-diabetic” conditions?[J].Biomolecules, 2021, 11(7):992.
|
| [53] |
TZOUNAKAS V L, KRIEBARDIS A G, PAPASSIDERI I S, et al. Donor-variation effect on red blood cell storage lesion:a close relationship emerges[J].Proteomics Clin Appl, 2016, 10(8):791-804.
|
| [54] |
HOD E A, BRITTENHAM G M, BITAN Z C, et al. A randomized trial of blood donor iron repletion on red cell quality for transfusion and donor cognition and well-being[J].Blood, 2022, 140(25):2730-2739.
|
| [55] |
JACOBS J W, BATES I, M’BAYA B, et al. Ensuring a safe and sufficient global blood supply[J].N Engl J Med, 2024, 391(12):1079-1081.
|
| [56] |
LI L, LI K Y, YAN K, et al. The history and challenges of blood donor screening in China[J].Transfus Med Rev, 2017, 31(2):89-93.
|
| [57] |
SHI L, WANG J, LIU Z, et al. Blood donor management in China[J].Transfus Med Hemother, 2014, 41(4):273-282.
|
基金资助
基地平台建设项目(医科院重点实验室)(2018PT32016)